Off-label Drug Use For Geriatric Patient with Degenerative Disease at Pharmacy in Surakarta

  • Nila Darmayanti Lubis
  • Santi Dwi Astuti Universitas Setia Budi Surakarta

Abstract

ABSTRACT

               Off-label drug use in geriatric patients who have degenerative diseases has the potential to cause medication errors or adverse drug reactions but off-label is not always bad and harmful. The purpose of this study was to determine the prevalence of off-label drug use in the categories of indication, dosage, contraindication and age in geriatric patients with degenerative diseases.               This study used a descriptive design. Data were collected by retrospectively. Samples were taken with a purposive sampling technique from several Pharmaceutical Installation in the Surakarta that served prescriptions with inclusion criteria for geriatric patients with degenerative diseases, prescriptions were written by specialists, prescriptions were redeemed at pharmacies that had collaborated with specialist doctors, prescriptions that had complete information, prescriptions that entered the pharmacy in April-May 2019 and matched the information on the use of the drug with the medicine leaflet.               The evaluation results of the use of off-label drugs in geriatric patients with degenerative diseases in pharmacies in the Surakarta region are the prevalence of the use of off-label drug indicative categories of 7.6%; the prevalence of off-label drug use in the dose category is 33.92%; the prevalence of off-label drug use is contraindicated and age category is 0%.

Keywords: Geriatri, Degenerative, Off-label, Community Pharmacies of Surakarta

References

[1]. Amelia, R 2010, Dahsyatnya Terapi Herbal untuk Tujuh Penyakit Degeneratif, Pinang Merah, Yogyakarta, hal. 67-73.
[2]. Badan Pengawas Obat dan Makanan. 2014. Buku Informasi Obat Nasional Indonesia, Jakarta : Badan Pengawas Obat dan Makanan.
[3]. Purba, A. V. 2007, Penggunaan Obat Off-label Pada Pasien Anak. Buletin Penelitian Kesehatan, 35.
[4]. Amala, Dona 2018. Identifikasi Penggunaan Obat Off-label Indikasi Pada Pasien Geriatri Rawat Inap di RSUP Dr. Sardjito. http://repository.umy.ac.id/handle/123456789/22031
[5]. Dell’Aera M et all. 2007, Unlicensed and Off-label Use of Medicines at A Neonatology Clinic in Italy. Pharm World Sci; 361-7
[6]. Hamzah, R. (2016). Hubungan usia dan jenis kelamin dengan kualitas hidup pada penderita gagal jantung di RS PKU Muhammadiyah Yogyakarta. Universitas ‘Aisyiyah Yogyakarta
[7]. International Neuromodulation Society Public Education, 2016, Neuropathy, Neuropathic Pain, and Painful Peripheral Neuropathy: Many Kinds, Causes, and Treatments, Victoria Pain Specialists, Richmond, Australia: https://www.neuromodulation.com/fact_sheet_painful_peripheral_neuropathy
[8]. Soeroso J, Kertia N, Susanti VY. Nyeri neuropatik. In: Setiati S, Alwi I, Sudoyo AW, Simadibrata M, Setiyohadi B, Syam AF, editors. Buku ajar ilmu penyakit dalam. Edisi ke-6. Jakarta: InternaPublishing; 2014. h. 3541-8. Jurnal e-Clinic (eCl), Volume 4, Nomor 2, Juli-Desember 2016
[9]. Meliala L, Alexander J, Hartanto YB. 2011, Update in acute neuropathic pain. In : Gofir A, Karema W, Runtuwene T, Kembuan M, Khosama H, Mawuntu A, editors. Konas Perdossi ke-7; Manado. Pustaka cendikia press;
[10]. Thomas E.P, Widyadharma P.E, Wijayanti I.A, 2016. Management of Neurophatic Pain in Elderly Focus on Pregabalin. Bagian/SMF Neurologi FK.Universitas Udayana/RSUP Denpasar Bali.

[11]. Rahajeng, Bangunawati, Zullies Ikawati, Tri Murti Andayani, and Iwan Dwiprahasto. 2018. A Retrospective Study: The Off-Label Use of Anticonvulsants at A Private Hospital in Indonesia. International Journal of Pharmacy and Pharmaceutical Sciences 10 (5): 119. https://doi.org/10.22159/ijpps.2018v10i5.25388.
[12]. Chen H. 2004, Contemporary Management of Neuropathic Pain for the Primary Care Physician, Mayo Clin Proc, Vol. 79: 1533-1545, [cited 2019 June 18], available at: www.mayoclinicproceedings.com/inside.asp?AID
[13]. Gilron, I., 2005, Morphine, Gabapentin or Their Combination for Neuropathic Pain, N Engl J Med, Vol. 352., No. 13
[14]. Gota, V., & Divatia, J. V. (2015). Off-label use of drugs: An evil or a necessity US National Library of Medicine National Institutes of Health, 59(12): 767–768.
[15]. American Geriatric Society. 2012. Guiding Principles for the Care of Older Adults with Multimorbidity : An Approach for Clinicians American Geriatrics Society Expert Panel on the Care of Older Adults. In J Am Geriatr Soc (Vol. 60, pp. 1–26). https://doi.org/10.1111/j.1532-5415.2012.04188.x
Published
2021-04-05